X0203 3 2009-01-30 0 0000827809 QLT INC/BC QLTI 0001451330 NB Public Equity K/S OESTERGADE 5, 3RD FLOOR, DK-1100 COPENHAGEN K, DENMARK G7 DENMARK 0 0 1 0 0001451332 NB Public Equity Komplementar ApS OESTERGADE 5, 3RD FLOOR, DK-1100 COPENHAGEN K, DENMARK G7 DENMARK 0 0 1 0 0001451331 Madsen Cora OESTERGADE 5, 3RD FLOOR, DK-1100 COPENHAGEN K, DENMARK G7 DENMARK 0 0 1 0 0001360573 Hansen Christian OESTERGADE 5, 3RD FLOOR, DK-1100 COPENHAGEN K, DENMARK G7 DENMARK 0 0 1 0 0001360509 Schonharting Florian OESTERGADE 5, 3RD FLOOR, DK-1100 COPENHAGEN K, DENMARK G7 DENMARK 0 0 1 0 Common Shares, no par value 6513579 D These shares are owned directly by NB Public Equity K/S (the "Fund"). They are owned indirectly by NB Public Equity Komplementar ApS (the "General Partner"), which is the general partner of the Fund and may be deemed to be the beneficial owner of the securities held by the Fund by reason of its managment of the Fund. The shares are also indirectly owned by Cora Madsen, who has the legal power to vote or dispose of the shares beneficially owned by the Fund as Director of the General Partner, and Christian Hansen and Florian Schonharting, who are directors of Nordic Biotech Advisors ApS, which owns 100% of the General Partner. Each of the foregoing indirect owners of the securities hereby disclaims any beneficial ownership of all such securities for purposes of Section 16 of the Securities Exchange Act of 1934, except to the extent of their pecuniary interest therein. /s/ James E. Dawson, as attorney in fact 2009-02-06